Skip Nav Destination
Drug Discovery
Emerging Drugs and Targets for Multiple Sclerosis
Edited by
Ana Martinez
Ana Martinez
Centro de Investigaciones Biologicas-CSIC, Spain
Search for other works by this author on:
Hardback ISBN:
978-1-78801-450-2
PDF ISBN:
978-1-78801-607-0
EPUB ISBN:
978-1-78801-806-7
Special Collection:
2019 ebook collection
Series:
Drug Discovery Series
No. of Pages:
333
Published online:
18 Jun 2019
Published in print:
28 Jun 2019
Book Chapter
CHAPTER 3: Biomarkers for Multiple Sclerosis
By
Amalia Tejeda Velarde
;
Amalia Tejeda Velarde
Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS)
Spain
Red Española de Esclerosis Múltiple (REEM)
Spain
Search for other works by this author on:
Silvia Medina Heras
;
Silvia Medina Heras
Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS)
Spain
Red Española de Esclerosis Múltiple (REEM)
Spain
Search for other works by this author on:
Luisa María Villar Guimerans
Luisa María Villar Guimerans
Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS)
Spain
Red Española de Esclerosis Múltiple (REEM)
Spain
Search for other works by this author on:
-
Published:18 Jun 2019
-
Special Collection: 2019 ebook collectionSeries: Drug Discovery Series
Page range:
55 - 75
Citation
A. T. Velarde, S. M. Heras, and L. M. Villar Guimerans, in Emerging Drugs and Targets for Multiple Sclerosis, ed. A. Martinez, The Royal Society of Chemistry, 2019, pp. 55-75.
Download citation file:
A biomarker is “a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions”. Biomarkers can include molecular, histologic, radiographic, or physiologic characteristics. Biomarkers in multiple sclerosis are crucial and could help in diagnosis, prognosis and monitoring of treatment. This chapter describes multiple sclerosis biomarkers used in clinical practice as well as relevant potential biomarkers.
You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Digital access
$64.60
